Baijin Life Science HoldingsMNNGF 34 Current Ratio is 4.21 as of Sep. 2025, which is 0% below its 10-year median of 4.23. GuruFocus rates MNNGF with a GF Score™ of 34/100 and a GF Value™ of $0.04. The stock has 6 warning signs investors should review. Among 1,127 Retail - Cyclical companies, Baijin Life Science Holdings ranks better than 87.84% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Baijin Life Science Holdings's current ratio for the quarter that ended in Sep. 2025 was 4.21.
Baijin Life Science Holdings has a current ratio of 4.21. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Baijin Life Science Holdings's Current Ratio or its related term are showing as below:
MNNGF'
s Current Ratio Range Over the Past 10 Years
Min: 1.19 Med: 4.23 Max: 13.51
Current: 4.21
During the past 12 years, Baijin Life Science Holdings's highest Current Ratio was 13.51. The lowest was 1.19. And the median was 4.23.
MNNGF's Current Ratio is ranked better than 87.84% of 1127
companies
in the Retail - Cyclical industry
Industry Median: 1.57
vs MNNGF: 4.21
Baijin Life Science Holdings (OTCPK:MNNGF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Baijin Life Science Holdings Current Ratio Related Terms
Baijin Life Science Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Current Ratio vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings (MNNGF) has a Current Ratio of 4.21 as of Sep. 2025. This is near median its historical median of 4.23. Over the past decade, Baijin Life Science Holdings' Current Ratio has ranged from 1.19 to 13.51. According to the industry distribution chart, Baijin Life Science Holdings ranks #137 out of 1127 companies in the Retail - Cyclical industry, placing it in the top 12.2%.
Is Baijin Life Science Holdings' Current Ratio too high?
Baijin Life Science Holdings' current Current Ratio of 4.21 is near median its 10-year median of 4.23. Over the past 10 years, this metric has ranged from a low of 1.19 to a high of 13.51. The Retail - Cyclical industry median Current Ratio is 1.57. Baijin Life Science Holdings' value of 4.21 is 168.2% above this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #137 out of 1127 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Current Ratio compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #137 out of 1127 companies for Current Ratio. This places Baijin Life Science Holdings in the top 12% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.57. Baijin Life Science Holdings' value of 4.21 is 168.2% above this benchmark. Historically, Baijin Life Science Holdings' own Current Ratio has ranged from 1.19 to 13.51 over the past decade. While the company's 10-year median is 4.23 vs. the industry median of 1.57, Baijin Life Science Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Retail - Cyclical company?
The median Current Ratio among Retail - Cyclical companies is 1.57, based on 1,127 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Current Ratio of 4.21 is 168.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Retail - Cyclical industry, the median Current Ratio is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Current Ratio is 4.21, which is near median its own 10-year median of 4.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Current Ratio of 4.21. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Current Ratio is 4.21, which is near median its 10-year median of 4.23 and 168.2% above the Retail - Cyclical industry median of 1.57. Baijin Life Science Holdings' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Current Ratio is 4.21 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.
Key valuation signals for MNNGF:
Current Ratio: 4.21 (near median its 10-year median of 4.23)
GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
Industry Position: 168.2% above the Retail - Cyclical median (#137 of 1127)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
34GF Score
Get the complete analysis for MNNGF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
